
[BIO KOREA 2025] MSD bets big on Korean biotech for open innovation
Global pharmaceutical giant MSD is accelerating its open innovation strategy in Korea, highlighting its growing number of partnerships with local biotech firms and an expanding clinical footprint in the country. At the Bio Korea 2025 conference held in …